Singleron to Launch Tensor at Festival of Genomics, Setting New Standards in Single Cell Sequencing Automation 21.01.20252’Cologne, Germany – January 21, 2025 – Singleron Biotechnologies will introduce the Tensor High Throughput Single Cell Library Processing System, the first fully automated instrument for single cell sequencing library preparation, from cell suspension to sequencing-ready library, to address the increased needs for throughput and automation in the field. Tensor enables the preparation of up to 32 single cell sequencing libraries of up to 3 million cells in a single run, reducing hands-on time by 90% and completing the process in a single workday.Tensor: A New Standard in High Throughput Single Cell Sequencing AutomationTensor addresses key challenges in single cell workflows, including procedural complexity and manual workload. Singleron’s SCOPE-Adaptor technology not only empowers its Tensor system, but also works as a nimble module that can be integrated in the most commonly used liquid handler systems customers already have in their laboratories.End-to-End Automation SolutionsWhile Tensor automates the critical steps of single cell partitioning and library preparation, it complements Singleron’s existing portfolio, which includes automation solutions for tissue dissociation, cloud-based data analysis, and data interpretation. Together, these products automate and standardize the comprehensive end-to-end workflow for single cell sequencing—from tissue to data, making single cell sequencing ready for clinical translations and applications.Live Product Launch at Festival of Genomics, LondonAt the Festival of Genomics in London, January 29-30 2025, Singleron will present the concepts of Tensor and its Early Access Program.Join us for the live event at 4:00 PM on January 29 at booth #187. To register for the event, visit https://singleron.bio/news/single-cell-workflow-automation-fog2025/.About Singleron BiotechnologiesFounded in 2018, Singleron Biotechnologies is dedicated to advancing human health through pioneering single cell multi-omics solutions. With a portfolio that includes instruments, reagents, bioinformatics software, and a comprehensive single cell knowledgebase, Singleron operates globally with offices and facilities in Germany, Singapore, the USA, and China. Singleron products are used in over 4,000 laboratories worldwide, spanning hospitals, research institutes, and pharmaceutical companies. For more information, visit https://singleron.bioCheck out our latest news and events Learn more 26.01.13 Singleron Biotechnologies Appoints Garvan Institute of Medical Research as their Australia Certified Service Provider Singapore, 13 January 2026 – Singleron Biotechnologies, distributed by DKSH in Australia and New Zealand, and Garvan Institute of Medical Research announced their strategic alliance, marking a significant step… Read more 26.01.07 Singleron and DKSH Announce Strategic Partnership to Expand Access to Single Cell Multi-Omics Solutions in Australia and New Zealand Singapore, 7 January 2026 – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of… Read more 25.11.14 Singleron's Matrix NEO™ Receives World's First Class II Medical Device Approval for Automated Single Cell Analysis Regulatory milestone enables single cell sequencing to enter routine clinical diagnostics COLOGNE, GERMANY – November 14, 2025 – Singleron Biotechnologies announced today that its Matrix… Read more
26.01.13 Singleron Biotechnologies Appoints Garvan Institute of Medical Research as their Australia Certified Service Provider Singapore, 13 January 2026 – Singleron Biotechnologies, distributed by DKSH in Australia and New Zealand, and Garvan Institute of Medical Research announced their strategic alliance, marking a significant step… Read more
26.01.07 Singleron and DKSH Announce Strategic Partnership to Expand Access to Single Cell Multi-Omics Solutions in Australia and New Zealand Singapore, 7 January 2026 – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of… Read more
25.11.14 Singleron's Matrix NEO™ Receives World's First Class II Medical Device Approval for Automated Single Cell Analysis Regulatory milestone enables single cell sequencing to enter routine clinical diagnostics COLOGNE, GERMANY – November 14, 2025 – Singleron Biotechnologies announced today that its Matrix… Read more